CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 40 enrolled
Drug / intervention
green tea tablets (Green tea extract 5:1) 200 mg +1 moredrug
Likely dose
green tea tablets (Green tea extract 5:1) 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02329600
NCT02329600Phase 3Completed

Evaluation of Systemic Administration of Green Tea Polyphenols as a Supportive Antioxidant Agent in the Management of Oral Lichen Planus

Cairo University·interventional·Posted Dec 31, 2014·Updated Nov 15, 2016

In Brief

A Phase 3 clinical trial evaluating green tea tablets (Green tea extract 5:1) 200 mg and Triamcinolone Acetonide for Oral Lichen Planus. Completed, enrolled 40 participants.

Detailed Summary

The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 31, 2014
Enrollment StartJun 1, 2013
Primary CompletionAug 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.5 years ago

Interventions

green tea tablets (Green tea extract 5:1) 200 mgdrug

Green tea is a product made from the Camellia sinensis plant. The fresh leaves are used to make medicine. the green tea extract is presented in a form of tablets 200 mg and is taken orally.

Triamcinolone Acetonidedrug

topical corticosteroids (Kenalog in orabase: Bristol-Myers, Squibb, Spain) applied topically 4 times a day i.e. following each meal and at bed time for one month